MedPath
HSA Approval

URSOFALK CAPSULE 250 mg

SIN05742P

URSOFALK CAPSULE 250 mg

URSOFALK CAPSULE 250 mg

April 8, 1991

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

Pending

xpending

Manufacturer Information

DCH AURIGA SINGAPORE

Losan Pharma GmbH - Werk Neuenburg

Losan Pharma GmbH (Primary & Secondary Packager)

Active Ingredients

URSODEOXYCHOLIC ACID

250 mg

Ursodeoxycholic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

URSOFALK CAPSULE 250 mg - HSA Approval | MedPath